Skip to content

Is There a Comorbidity Between Migraine and Allergic Rhinitis?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01845051
Enrollment
80
Registered
2013-05-03
Start date
2012-11-30
Completion date
2013-03-31
Last updated
2013-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis, Migraine

Keywords

Migraine, allergic rhinitis, Specific Immunoglobulin E (IgE), nasal symptoms, signs of allergy.

Brief summary

The researchers investigated the relationship between migraine and allergy. For this purpose, the researchers designed a controlled study to evaluate nasal symptoms and signs; and to perform Specific Immunoglobulin E (IgE) measurements in migraine patients and healthy subjects. According to these results the prevalence of allergic rhinitis in migraine group was planned to be compared to that of the healthy controls, statistically.

Interventions

None listed

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* patients with migraine

Exclusion criteria

* other neurologic disorders that may contribute to headaches, such as stroke, cerebral palsy, trigeminal neuralgia, and seizure disorder * also acute and chronic sinusitis.

Design outcomes

Primary

MeasureTime frameDescription
Specific Immunoglobulin E (IgE)1 dayBlood samples were taken from study and control group for the determination of Specific IgE panel against six different allergens: (1) fungi, (2) grass pollens, (3) tree pollens, (4) wild herbs, (5) mite 1, (6) mite 2. For all of specific IgE panels, \<0,7 RU/ml was negative; and \>0,7 RU/ml was Positive.
Nasal Symptom Scores1 daySymptoms were assessed with a questionnaire for the presence and severity of allergic rhinitis (AR) symptoms on a scale of 0-3 (0 = none, 1 = mild, 2 = moderate, 3 = severe). Symptoms of AR (Nasal discharge, nasal congestion, itching and sneezing) were graded between 0-3.

Other

MeasureTime frameDescription
İnferior turbinate color and edema1 dayinferior concha colour (0=natural, 1=pale, 2=bluish and 3=severely pale or bluish) and turbinate edema were assessed during ENT examination on 0-3 scale (0 = no, 1 = mild, 2 = moderate, 3 = severe).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026